These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 6255050)

  • 1. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 2. Herpes simplex virus. An expanding relationship to human cancer.
    Smith JW
    J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 4. Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients.
    Heise ER; Kucera LS; Raben M; Homesley H
    Cancer Res; 1979 Oct; 39(10):4022-6. PubMed ID: 225014
    [No Abstract]   [Full Text] [Related]  

  • 5. Herpes simplex virus and human papilloma virus in the development of cervical carcinoma.
    Kaufman RH; Adam E
    Clin Obstet Gynecol; 1986 Sep; 29(3):678-92. PubMed ID: 3019599
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
    Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
    Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L
    Cancer Res; 1974 May; 34(5):1126-35. PubMed ID: 4367156
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L
    Clin Orthop Relat Res; 1974; (99):78-85. PubMed ID: 4363067
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serological aspects of the relation between herpes virus and cervico-uterine cancer].
    Suárez M; Del Campo G; Ojeda JM
    Rev Chil Obstet Ginecol; 1983; 48(1):11-5. PubMed ID: 6099904
    [No Abstract]   [Full Text] [Related]  

  • 10. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
    Gilman SC; Docherty JJ; Clarke A; Rawls WE
    Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of herpes simplex-associated antigens and antibodies in patients with cervical carcinoma in Buenos Aires.
    Teyssié AR; Ayerra de Holstein B; Alonio L; Distéfano A; Lucero J; Pasqualini RS; de Torres RA
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(2):123-7. PubMed ID: 6258793
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of antibodies against herpes simplex and adenovirus in oral and cervical cancer patients--a preliminary report.
    Kumari TV; Shanmugam J; Prabha B; Vasudevan DM
    Indian J Med Res; 1982 Apr; 75():590-2. PubMed ID: 6286474
    [No Abstract]   [Full Text] [Related]  

  • 13. Herpes simplex virus type-specific antibodies detected by indirect and competition ELISA. Comparison of sera from patients with carcinoma of the uterine cervix, age matched controls and patients with recurrent genital herpes.
    Najem SN; Vestergaard BF; Potter CW
    Acta Pathol Microbiol Immunol Scand B; 1983 Jun; 91(3):205-7. PubMed ID: 6308950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix.
    Athanasiu P; Nastac E; Stoian M; Predescu E; Hozoc M
    Virologie; 1978; 29(4):251-3. PubMed ID: 219590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to membrane antigens of herpes simplex virus type-2 infected cells and HSV-2 specific antibodies in patients with cervical cancer in Malawi.
    Chiphangwi JD
    IARC Sci Publ; 1984; (63):465-70. PubMed ID: 6100279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of HSV-2-induced early antigen with antibodies from cervical carcinoma patients].
    Jiang JW
    Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):107-9, 126. PubMed ID: 3017644
    [No Abstract]   [Full Text] [Related]  

  • 18. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between immune complexes and herpes simplex virus (HSV)-tumor associated antigen (TAA) in human cancer sera.
    Cocchiara R; Tarro G; Flaminio G; Geraci D
    Cell Mol Biol; 1983; 29(5):397-403. PubMed ID: 6313196
    [No Abstract]   [Full Text] [Related]  

  • 20. Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.
    Thiry L; Sprecher-Goldberger S; Hannecart-Pokorni E; Gould I; Bossens M
    Cancer Res; 1977 May; 37(5):1301-6. PubMed ID: 192446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.